Work

Phase II study of three hour, weekly infusion of trabectedin (ET-743) in men with metastatic, androgen-independent prostate carcinoma (AIPC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4517

Authors: M. D. Michaelson, T. Gilligan, W. Oh, P. Kantoff, M.-E. Taplin, M. A. Izquierdo, L. Flores, M. R. Smith

Institutions: Massachusetts General Hospital, PharmaMar (Spain), Dana-Farber Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W59659877

Cites:

Cited by: 14

Related to: 10